YX-2-107

• CAT Number: I042299
• CAS Number: 2417408-46-7
• Molecular Formula: C45H51N11O9
• Molecular Weight: 889.95
• Purity: ≥95%
• Synonyms: N-[4-[[2-[4-[6-[(6-acetyl-8-cyclopentyl-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazin-1-yl]-2-oxoethyl]amino]butyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide
• InChI: InChI=1S/C45H51N11O9/c1-26-31-23-49-45(52-40(31)55(28-8-3-4-9-28)43(63)38(26)27(2)57)50-34-14-12-29(22-48-34)53-18-20-54(21-19-53)37(60)24-46-16-5-6-17-47-36(59)25-65-33-11-7-10-30-39(33)44(64)56(42(30)62)32-13-15-35(58)51-41(32)61/h7,10-12,14,22-23,28,32,46H,3-6,8-9,13,15-21,24-25H2,1-2H3,(H,47,59)(H,51,58,61)(H,48,49,50,52)
• InChIKey: JNYCZFGLJGFFEL-UHFFFAOYSA-N
• SMILES: CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCN(CC4)C(=O)CNCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C6=O)C7CCC(=O)NC7=O)C8CCCC8)C(=O)C

YX-2-107（Cat No.:I042299）is a small molecule compound under investigation for its potential therapeutic applications, particularly in oncology. It functions as a selective inhibitor of specific signaling pathways involved in tumor growth, survival, and resistance to treatment. By targeting key proteins or enzymes in these pathways, YX-2-107 aims to reduce tumor cell proliferation and enhance the effectiveness of existing cancer therapies. Preclinical studies have shown promise in inhibiting various types of cancer. Ongoing clinical trials are focused on evaluating its safety, pharmacokinetics, and efficacy as a potential treatment for cancer and other diseases.